Main Content

Selected Advanced Malignancies

Study title

A Phase 1, Open–Label, Dose-Escalation, Safety and Tolerability Study of INCAGN02390 in Participants with Select Advanced Malignancies

  • Principal Investigator: Dr. Shou Ching Tang


The purpose of this study is to look at the safety and effectiveness of the experimental drug to see how it reacts to the body and how it is broken down and removed from the body.

Who can participate

Those eligible to participate in this study include:

  • Women and men ages 18 and older.

For more information

  • Teresa Witcher
    University of Mississippi Medical Center
    2500 N. State St.
    Jackson, MS 39216
    (601) 984-6991
  • IRB Number: 2018-0154